Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a


Tratamentul tulburărilor obsesiv-compulsive



Yüklə 4,39 Mb.
səhifə15/50
tarix25.07.2018
ölçüsü4,39 Mb.
#58042
1   ...   11   12   13   14   15   16   17   18   ...   50

Tratamentul tulburărilor obsesiv-compulsive.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AB08 FLUVOXAMINUM COMPR. FILM. 100 mg

FEVARIN(R) 100 100 mg SOLVAY PHARMACEUTICALS BV

FLUVOXAMINE TEVA 100 mg 100 mg TEVA PHARMACEUTICALS SRL


N06AB08 FLUVOXAMINUM COMPR. FILM. 50 mg

FEVARIN(R) 50 50 mg SOLVAY PHARMACEUTICALS BV

FLUVOXAMINE TEVA 50 mg 50 mg TEVA PHARMACEUTICALS SRL

________________________________________________________________________________


______________________________________________________________________________

| 136 |N06AX03| MIANSERINUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AX03 MIANSERINUM COMPR. FILM. 10 mg

MIANSERIN 10 10 mg REMEDICA LTD.
N06AX03 MIANSERINUM DRAJ. 10 mg

MIANSERIN 10 mg 10 mg TERAPIA SA


N06AX03 MIANSERINUM COMPR. FILM. 30 mg

MIANSERIN 30 30 mg REMEDICA LTD.


N06AX03 MIANSERINUM DRAJ. 30 mg

MIANSERIN 30 mg 30 mg TERAPIA SA

________________________________________________________________________________
______________________________________________________________________________

| 137 |N06AX11| MIRTAZAPINUM* | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul episoadelor depresive majore.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AX11 MIRTAZAPINUM COMPR. DISP. 15 mg

REMERON(R) SOLTAB 15 mg 15 mg ORGANON NV
N06AX11 MIRTAZAPINUM COMPR. FILM. 15 mg

ESPRITAL(R) 15 15 mg ZENTIVA AS

MIRZATEN(R) 15 mg 15 mg KRKA D.D.
N06AX11 MIRTAZAPINUM COMPR. DISP. 30 mg

REMERON(R) SOLTAB 30 mg 30 mg ORGANON NV


N06AX11 MIRTAZAPINUM COMPR. FILM. 30 mg

ESPRITAL(R) 30 30 mg ZENTIVA AS

MIRTAZAPINE-TEVA 30 mg 30 mg TEVA PHARMACEUTICALS SRL

MIRZATEN(R) 30 mg 30 mg KRKA D.D.

PHARMATAZ 30 mg 30 mg ACTAVIS GROUP HF.
N06AX11 MIRTAZAPINUM COMPR. DISP. 45 mg

REMERON(R) SOLTAB 45 mg 45 mg ORGANON NV


N06AX11 MIRTAZAPINUM COMPR. FILM. 45 mg

ESPRITAL(R) 45 45 mg ZENTIVA AS

MIRZATEN(R) 45 mg 45 mg KRKA D.D.

________________________________________________________________________________


______________________________________________________________________________

| 138 |N06AX16| VENLAFAXINUM** | Protocol: N013F |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AX16 VENLAFAXINUM CAPS. ELIB. PREL. 150 mg

EFECTIN ER 150 mg 150 mg WYETH LEDERLE PHARMA GMBH

VELAXIN 150 mg 150 mg EGIS PHARMACEUTICALS

P.L.C.
N06AX16 VENLAFAXINUM COMPR. 37.5 mg

VELAXIN 37,5 mg 37.5 mg EGIS PHARMACEUTICALS PLC

VENLAFAXINA LPH 37,5 mg 37.5 mg LABORMED PHARMA SA
N06AX16 VENLAFAXINUM CAPS. ELIB. PREL. 75 mg

EFECTIN ER 75 mg 75 mg WYETH LEDERLE PHARMA GMBH

VELAXIN 75 mg 75 mg EGIS PHARMACEUTICALS

P.L.C.
N06AX16 VENLAFAXINUM COMPR. 75 mg

VELAXIN 75 mg 75 mg EGIS PHARMACEUTICALS PLC

VENLAFAXINA LPH 75 mg 75 mg LABORMED PHARMA SA

________________________________________________________________________________
______________________________________________________________________________

| 139 |N07AA01| NEOSTIGMINI BROMIDUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N07AA01 NEOSTIGMINI BROMIDUM SOL. INJ. 0.5 mg/ml

MIOSTIN 0,5 mg/ml 0.5 mg/ml ZENTIVA S.A.
N07AA01 NEOSTIGMINI BROMIDUM COMPR. 15 mg

NEOSTIGMINA LPH 15 mg 15 mg LABORMED PHARMA SA

________________________________________________________________________________
______________________________________________________________________________

| 140 |P01AB01| METRONIDAZOLUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul infecţiilor cu anaerobi.

Tratamentul infecţiilor cu protozoare sensibile la

metronidazol.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

P01AB01 METRONIDAZOLUM COMPR. 250 mg

METRONIDAZOL 250 mg (P01AB01) 250 mg ZENTIVA SA

METRONIDAZOL 250 mg (P01AB1) 250 mg ARENA GROUP SA


P01AB01 METRONIDAZOLUM COMPR. FILM. 250 mg

FLAGYL 250 mg LABORATOIRE AVENTIS


P01AB01 METRONIDAZOLUM SUSP. ORALA 4%

FLAGYL 4% (P01AB01) 4% LABORATOIRE AVENTIS

________________________________________________________________________________
______________________________________________________________________________

| 141 |P01AB02| TINIDAZOLUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul infecţiilor cu anaerobi.

Tratamentul infecţiilor cu protozoare sensibile la

metronidazol.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

P01AB02 TINIDAZOLUM COMPR. FILM. 500 mg

FASIGYN (P01AB02) 500 mg PFIZER EUROPE MA EEIG

TINIZOL(R) 500 mg (P01AB02) 500 mg ZENTIVA S.A.

TIPROGYN 500 500 mg AC HELCOR SRL
P01AB02 TINIDAZOLUM COMPR. FILM. 500 mg

FASIGYN (P01AB02) 500 mg PFIZER EUROPE MA EEIG

TINIZOL(R) 500 mg (J01XD02) 500 mg ZENTIVA S.A.

TIPROGYN 500 500 mg AC HELCOR SRL

________________________________________________________________________________
______________________________________________________________________________

| 142 |P02CA03| ALBENDAZOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

P02CA03 ALBENDAZOLUM SUSP. ORALA 0.4 g/10 ml

ZENTEL 0,4 g/10 ml 0.4 g/10 ml GLAXOSMITHKLINE EXPORT

LTD.
P02CA03 ALBENDAZOLUM COMPR. FILM. 200 mg

DUADOR 200 mg 200 mg GEDEON RICHTER ROMANIA SA

ZENTEL 200 mg 200 mg GLAXOSMITHKLINE EXPORT

LTD.
P02CA03 ALBENDAZOLUM COMPR. 400 mg

ESKAZOLE 400 mg GLAXO SMITHKLINE EXPORT

LTD.
P02CA03 ALBENDAZOLUM SUSP. ORALA 400 mg

ALBENDAZOL BIOFARM 400 mg 400 mg BIOFARM S.A.


P02CA03 ALBENDAZOLUM COMPR. FILM 200 mg

ALBENDAZOL 200 mg OZONE LABORATORIES LTD.

________________________________________________________________________________
______________________________________________________________________________

| 143 |P02CE01| LEVAMISOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

P02CE01 LEVAMISOLUM COMPR. 150 mg

DECARIS 150 mg 150 mg GEDEON RICHTER ROMANIA SA
P02CE01 LEVAMISOLUM COMPR. 50 mg

DECARIS 50 mg 50 mg GEDEON RICHTER ROMANIA SA

________________________________________________________________________________
______________________________________________________________________________

| 144 |R03AC02| SALBUTAMOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R03AC02 SALBUTAMOLUM SUSP. INHAL PRESURIZATĂ 100 µg/doză

ASTHALIN INHALER 100 µg/doză CIPLA (UK) LIMITED

ECOSAL Easi-Breath 100 µg/doză IVAX-PHARMACEUTICALS

S.R.O.

VENTOLIN 100 INHALER CFC-FREE 100 µg/doză GLAXOWELLCOME UK LTD.


R03AC02 SALBUTAMOLUM SOL. INHAL. 5 mg/ml

VENTOLIN(R) 5 mg/ml GLAXOWELLCOME UK LTD.

________________________________________________________________________________
______________________________________________________________________________

| 145 |R03BA01| BECLOMETASONUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R03BA01 BECLOMETASONUM AEROSOL SOL. INHAL. 100 µg/doză

ECOBEC 100 µg 100 µg/doză IVAX-PHARMACEUTICALS

CFC FREE S.R.O.

ECOBEC EASI-BREATHE 100 µg/doză IVAX-PHARMACEUTICALS

100 µg CFC FREE S.R.O.


R03BA01 BECLOMETASONUM SPRAY NAZ., SUSP. 100 µg/doză

RINOCLENIL 100 100 µg/doză CHIESI FARMACEUTICI S.P.A.


R03BA01 BECLOMETASONUM AEROSOL SOL. INHAL. 250 µg/doză

ECOBEC 250 µg/doză 250 µg/doză IVAX-PHARMACEUTICALS

CFC FREE S.R.O.

ECOBEC EASI-BREATHE 250 µg/doză IVAX-PHARMACEUTICALS

250 µg/doză CFC FREE S.R.O.
R03BA01 BECLOMETASONUM SOL. DE INHALAT 250 µg/doză

PRESURIZATĂ

BECLOFORTER(R) CFC-Free 250 µg/doză GLAXO WELLCOME UK LTD.
R03BA01 BECLOMETASONUM SOL. INHALAT 250 µg/doză

PRESURIZATĂ

CLENIL(R) JET 250 µg/doză CHIESI FARMACEUTICI SPA

250 µg/doză


R03BA01 BECLOMETASONUM SOL. DE INHALAT 50 µg/doză

PRESURIZATĂ

BECOTIDER(R) CFC-Free 50 µg/doză GLAXO WELLCOME UK LTD.

________________________________________________________________________________


______________________________________________________________________________

| 146 |R03BA02| BUDESONIDUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R03BA02 BUDESONIDUM PULB. INHAL. 200 µg/doză

FRENOLYN 200 200 µg/doză MEDOCHEMIE ROMÂNIA SRL
R03BA02 BUDESONIDUM PULB. INHAL. 200 µg/doză

PULMICORT TURBUHALER 200 µg/doză ASTRAZENECA AB

200 µg/doză
R03BA02 BUDESONIDUM PULB. INHAL. 400 µg/doză

FRENOLYN 400 400 µg/doză MEDOCHEMIE ROMÂNIA SRL

________________________________________________________________________________
______________________________________________________________________________

| 147 |R03BB01| IPRATROPII BROMIDUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R03BB01 IPRATROPII BROMIDUM AEROSOL 20 µg/doză

IPRAVENT 20 - INHALER 20 µg/doză CIPLA (UK) LIMITED

________________________________________________________________________________


______________________________________________________________________________

| 148 |R03CC02| SALBUTAMOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R03CC02 SALBUTAMOLUM SOL. ORALA 0.04%

SALBUTAMOL T 0.04% TIS FARMACEUTIC SA
R03CC02 SALBUTAMOLUM SOL. INJ. 0.5 mg/ml

VENTOLIN(R) 0.5 mg/ml GLAXO WELLCOME UK LTD.


R03CC02 SALBUTAMOLUM SIROP 2 mg/5 ml

SALBUTAMOL EIPICO 2 mg/5 ml 2 mg/5 ml E.I.P.I.CO. MED S.R.L.

VENTOLIN(R) 2 mg/5 ml GLAXOWELLCOME UK LTD.
R03CC02 SALBUTAMOLUM SOL. ORALA 2 mg/5 ml

SALBUTAMOL 2 mg/5 ml TERAPIA S.A.

________________________________________________________________________________
______________________________________________________________________________

| 149 |R03DA04| THEOPHYLLINUM | |

|_______|_______|____________________________________________|_________________|
Datorită efectelor variabile ale alimentelor asupra absorbţiei teofilinei, pacienţii care folosesc un anumit preparat nu trebuie să îi schimbe cu un altul fără o monitorizare adecvată.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 100 mg

TEOFIUNA SR 100 mg 100 mg TERAPIA SA

THEO SR 100 100 mg GLAXOSMITHKLINE (GSK) SRL


R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 200 mg

TEOFIUNA SR 200 mg 200 mg TERAPIA SA

TEOTARD(R) 200 200 mg KRKA D.D.

THEO SR 200 200 mg GLAXOSMITHKLINE (GSK) SRL


R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 300 mg

TEOFILINA SR 300 mg 300 mg TERAPIA SA

THEO SR 300 300 mg GLAXOSMITHKLINE (GSK) SRL
R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 350 mg

TEOTARD(R) 350 350 mg KRKA D.D.


R03DA04 THEOPHYLLINUM CAPS. ELIB. PREL. 50 mg

TEOFILINA SR 50 mg 50 mg TERAPIA SA

________________________________________________________________________________
______________________________________________________________________________

| 150 |R05DA04| CODEINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R05DA04 CODEINUM COMPR. 15 mg

CODEINA FOSFAT 15 mg SLAVIA PHARM SRL

CODEINA FOSFAT 15 mg 15 mg OZONE LABORATORIES LTD.

CODEINA FOSFAT LPH 15 mg 15 mg LABORMED PHARMA SA

CODEINA FOSFORICĂ 15 mg BIO EEL SRL

CODEINA FOSFORICĂ 15 mg 15 mg MAGISTRA C & C

FARMACOD 15 mg FARMACOM SA

FOSFAT DE CODEINĂ 15 mg 15 mg SINTOFARM SA

________________________________________________________________________________


______________________________________________________________________________

| 151 |R06AB04| CHLORPHENAMINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R06AB04 CHLORPHENAMINUM COMPR. 4 mg

CLORFENIRAMIN 4 mg LABORMED PHARMA SA

________________________________________________________________________________


______________________________________________________________________________

| 152 |R06AE07| CETIRIZINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R06AE07 CETIRIZINUM COMPR. FILM. 10 mg

CELERG 10 mg AC HELCOR PHARMA SRL
R06AE07 CETIRIZINUM COMPR. FILM. 10 mg

LETIZEN(R) 10 mg 10 mg KRKA D.D.


R06AE07 CETIRIZINUM SOL. ORALA 1 mg/ml

LETIZEN 1 mg/ml KRKA D.D.


R06AE07 CETIRIZINUM PICĂTURI ORALE - SOL. 10 mg/ml

ZYRTEC(R) 10 mg/ml U.C.B. GMBH

________________________________________________________________________________
______________________________________________________________________________

| 153 |R06AX17| KETOTIFENUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R06AX17 KETOTIFENUM CAPS. 1 mg

KETOF 1 mg 1 mg HEXAL AG
R06AX17 KETOTIFENUM COMPR. 1 mg

H-KETOTIFEN 1 mg AC HELCOR SRL

KETOTIFEN 1 mg MAGISTRA C & C

KETOTIFEN LPH(R) 1 mg 1 mg LABORMED PHARMA SA


R06AX17 KETOTIFENUM SIROP 1 mg/5 ml

FRENASMA 1 mg/5 ml FARAN LABORATORIES S.A.

KETOF 1 mg/5 ml 1 mg/5 ml HEXAL AG

________________________________________________________________________________


______________________________________________________________________________

| 154 |S01AX13| CIPROFLOXACINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

S01AX13 CIPROFLOXACINUM UNG. OFT. 0.3%

CIPLOX 0.3% CIPLA (UK) LIMITED

________________________________________________________________________________


______________________________________________________________________________

| 155 |S01BC03| DICLOFENACUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

S01BC03 DICLOFENACUM PICĂTURI OFT. - SOL. 0.1%

DICLOGESIC 0,1% PICĂTURI 0.1% DAR AL DAWA PHARMA S.R.L.

OFTALMICE, SOLUŢIE

UNICLOPHEN(R) 0,1% 0.1% UNIMED PHARMA LTD.

VOLTAREN OPHTHA CD 0.1% NOVARTIS PHARMA GMBH


S01BC03 DICLOFENACUM PIC. OFT. - SOL. 1 mg/ml

DICLOFENAC RPH 1 mg/ml ROMPHARM COMPANY SRL


S01BC03 DICLOFENACUM PIC. OFT. - SOL. 1 mg/ml

VURDON 1 mg/ml HELP S.A. PHARMACEUTICALS

________________________________________________________________________________
______________________________________________________________________________

| 156 |S01CA05| COMBINAŢII (BETHAMETASONUM + | |

| | | ANTIINFECŢIOASE) | |

|_______|_______|____________________________________________|_________________|


________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

S01CA05 COMBINAŢII UNG. OFT. 0,2 g + 0,5 g

(BETHAMETASONUM +

ANTIINFECŢIOASE)

BETABIOPTAL 0,2 g + 0,5 g FARMILA FARMACEUTICI
S01CA05 COMBINAŢII PICĂTURI OFT. SUSP. 0,2 g + 0,5 g

(BETHAMETASONUM +

ANTIINFECŢIOASE)

BETABIOPTAL 0,2 g + 0,5 g FARMILA FARMACEUTICI

MILANO SPA

________________________________________________________________________________


SUBLISTA B - MEDICAMENTE CU NIVEL DE COMPENSARE 50% DIN PREŢUL DE REFERINŢĂ
______________________________________________________________________________

| 157 |A02BC02| PANTOPRAZOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

A02BC02 PANTOPRAZOLUM COMPR. FILM. GASTROREZ. 20 mg

CONTROLOC 20 mg 20 mg ALTANA PHARMA AG
Prescriere limitată: Menţinerea rezultatelor terapiei refluxului gastro-esofagian

Prescriere limitată: Boala de reflux gastro-esofagian

Prescriere limitată: Profilaxia ulcerului gastro-duodenal asociat tratamentului cu antiinflamatoare nesteroidiene pe termen lung la pacienţii cu factori de risc gastrointestinal.


Yüklə 4,39 Mb.

Dostları ilə paylaş:
1   ...   11   12   13   14   15   16   17   18   ...   50




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin